Aehr test systems (AEHR)
Income statement / Quarterly
Feb'20Nov'19Aug'19May'19Feb'19Nov'18Aug'18May'18Feb'18Nov'17Aug'17May'17Feb'17Nov'16Aug'16May'16Feb'16Nov'15Aug'15May'15Feb'15Nov'14Aug'14May'14Feb'14Nov'13Aug'13May'13Feb'13Nov'12Aug'12May'12Feb'12Nov'11Aug'11May'11Feb'11Nov'10Aug'10
Net sales

6,111

6,874

5,533

7,242

3,163

5,911

4,740

7,269

7,393

7,923

6,970

6,683

2,681

4,216

5,318

1,571

1,677

4,620

6,633

1,818

2,027

2,615

3,558

5,370

5,612

4,950

3,752

3,262

3,340

5,054

4,832

4,676

2,855

3,860

4,130

3,749

4,242

3,577

2,169

Cost of sales

3,120

3,672

3,262

3,863

2,891

3,513

3,187

4,108

4,217

4,792

4,052

4,075

2,178

2,753

3,112

1,669

1,508

2,929

3,250

1,136

1,175

1,921

1,948

2,456

2,742

2,456

1,808

1,970

2,575

2,791

2,376

2,507

1,747

2,732

2,328

2,140

2,637

2,223

1,225

Gross profit

2,991

3,202

2,271

3,379

272

2,398

1,553

3,161

3,176

3,131

2,918

2,608

503

1,463

2,206

-98

169

1,691

3,383

682

852

694

1,610

2,914

2,870

2,494

1,944

1,292

765

2,263

2,456

2,169

1,108

1,128

1,802

1,609

1,605

1,354

944

Operating expenses:
Selling, general and administrative

1,891

2,157

1,808

2,018

1,850

1,977

1,879

1,816

1,829

1,854

1,791

1,905

1,724

1,707

1,716

1,722

1,695

1,713

1,845

1,526

1,584

1,736

1,624

1,685

1,701

1,517

1,420

1,504

1,511

2,068

1,789

1,872

1,525

1,528

1,601

1,465

1,486

1,495

1,518

Research and development

845

795

892

1,120

931

986

1,116

1,096

1,040

1,090

955

1,309

1,248

1,040

1,060

1,046

1,293

923

1,062

967

1,031

1,105

959

1,016

907

798

681

634

685

962

930

1,134

933

1,039

1,082

1,190

1,039

1,196

1,142

Restructuring

0

-

-

-

607

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on bankruptcy claim

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-155

Total operating expenses

2,736

2,952

2,700

3,256

3,388

2,963

2,995

2,912

2,869

2,944

2,746

3,214

2,972

2,747

2,776

2,768

2,988

2,636

2,907

2,493

2,615

2,841

2,583

2,701

2,608

2,315

2,101

2,138

2,196

3,030

2,719

3,006

2,458

2,567

2,683

1,978

2,525

2,691

2,505

Income (loss) from operations

255

250

-429

123

-3,116

-565

-1,442

249

307

187

172

-606

-2,469

-1,284

-570

-2,866

-2,819

-945

476

-1,811

-1,763

-2,147

-973

213

262

179

-157

-846

-1,431

-767

-263

-837

-1,350

-1,439

-881

-369

-920

-1,337

-1,561

Interest income (expense), net

13

-

-

-

-76

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1

2

Interest income (expense), net

-

-2

-12

-

-

74

78

89

98

105

107

141

178

181

178

168

165

137

135

101

7

8

14

5

7

10

4

6

18

13

12

4

0

0

0

-

-

-

-

Gain on sale of long-term investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

990

0

0

0

0

Other (expense) income, net

-9

5

10

17

-11

29

9

39

-33

-7

-60

-59

-2

43

-3

-23

-24

55

-24

10

110

60

31

21

-21

-30

-34

10

-9

-15

-19

64

7

58

-12

169

-30

579

44

Income (loss) before tax (expense) benefit

259

257

-407

116

-3,203

-610

-1,511

199

176

75

5

-806

-2,649

-1,422

-751

-3,057

-3,008

-1,027

317

-1,902

-1,660

-2,095

-956

229

234

139

-195

-842

-1,458

-795

-294

-777

-1,343

-1,381

97

-200

-950

-757

-1,515

Income tax (expense) benefit

14

6

6

6

-2

19

4

8

-91

15

-5

-11

2

30

4

-1

-33

21

23

-2

66

19

-49

-10

22

2

-29

12

0

16

2

2

18

-8

-27

-56

-4

10

1

Net income (loss)

245

251

-413

110

-3,201

-629

-1,515

191

267

60

10

-795

-2,651

-1,452

-755

-3,056

-2,975

-1,048

294

-1,900

-1,726

-2,114

-907

239

212

137

-166

-854

-1,458

-811

-296

-779

-1,361

-1,373

124

-

-

-

-

Less: Net income attributable to the noncontrolling interest

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-1

0

0

0

-

-

-

-

Net income (loss) attributable to Aehr Test Systems common shareholders

245

251

-413

110

-3,201

-629

-1,515

191

267

60

10

-795

-2,651

-1,452

-755

-3,056

-2,975

-1,048

294

-1,900

-1,726

-2,114

-907

239

212

137

-166

-854

-1,458

-811

-296

-780

-1,361

-1,373

124

-160

-946

-767

-1,516

Net loss per share: Basic and Diluted

-

-

-0.02

-

-

-

-0.07

-

-

-

-

-

-

-

-

-

-0.23

-0.08

-

-0.15

-0.14

-0.18

-0.08

-

-

-

-0.02

-

-

-

-0.03

-

-

-

-

-

-

-

-

Shares used in per share calculations: Basic and Diluted

-

-

22

-

-

-

22

-

-

-

-

-

-

-

-

-

13

13

-

-

12

11

-

-

-

-

10

-

-

-

9

-

-

-

-

-

-

-

-

Net income (loss) per share basic

0.01

0.01

-

-

-0.14

-0.03

-

-

0.01

0.00

0.00

-

-0.16

-0.09

-0.06

-

-

-

0.02

-

-

-

-

-

0.02

0.01

-

-

-0.16

-0.09

-

-

-0.15

-0.15

0.01

-

-0.11

-0.09

-0.17

Net income (loss) per share diluted

0.01

0.01

-

-

-0.14

-0.03

-

-

0.01

0.00

0.00

-

-0.16

-0.09

-0.06

-

-

-

0.02

-

-

-

-

-

0.02

0.01

-

-

-0.16

-0.09

-

-

-0.15

-0.15

0.01

-

-0.11

-0.09

-0.17

Shares used in per share calculations: basic (in thousands)

22

22

-

-

22

22

-

22

21

21

21

19

16

16

13

-

-

-

12

-

-

-

11

-

10

10

-

-

9

9

-

-26,930

9,055

8,980

8,932

-

8

8

8

Shares used in per share calculations: diluted (in thousands)

23

22

-

-

22

22

-

22

22

22

22

19

16

16

13

-

-

-

13

-

-

-

11

-

12

11

-

-

9

9

-

-27,098

9,055

8,980

9,100

-

8

8

8